From October 1, 2023 to December 31, 2023, the company has repurchased 95,700 shares, representing 0.27% for ¥315.81 million. With this, the company has completed the repurchase of 1,005,900 shares, representing 2.76% for ¥3,242.99 million under the buyback announced on May 15, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,205 JPY | +0.47% | +1.26% | -1.99% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.99% | 719M | |
+33.24% | 704B | |
+28.59% | 577B | |
-3.67% | 348B | |
+18.65% | 327B | |
+4.53% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.21% | 147B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.